Peter MacCallum Cancer Centre:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Peter MacCallum Cancer Centre - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9313
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Peter MacCallum Cancer Centre (Peter Mac) is a provider of public health services. It serves as a cancer research, treatment and education centre. The centre provides wide range of services including diagnostic, radiation therapy, treatment, cancer information and support services. It works in collaboration with various organizations and networks domestically and across the globe to provide cancer services. Peter Mac is headquartered in Melbourne, Victoria, Australia.

Peter MacCallum Cancer Centre – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Peter MacCallum Cancer Centre, Medical Devices Deals, 2012 to YTD 2018 9
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 11
Telix Pharma Enters into Research Partnership with University of Melbourne and Peter MacCallum Cancer Centre 12
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 13
Peter MacCallum Cancer Centre – Key Employees 14
Peter MacCallum Cancer Centre – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Recent Developments 16
Government and Public Interest 16
Aug 13, 2018: New insight into genetic drivers of aggressive prostate cancer 16
Jun 26, 2018: New understanding of how the immune system responds to breast cancer 17
Mar 01, 2018: Research into rare cancers receives funding boost 18
Feb 06, 2018: Commonwealth of Australia: Ground-breaking ovarian cancer project to save lives 19
Dec 13, 2017: Study Reveals A Role For Micro-RNAS In Cancer Cell Survival 21
Oct 17, 2017: New Potential Treatment for Prostate Cancer Receives Boost 22
Oct 09, 2017: Starpharma and Peter Mac Cancer Centre awarded DEP Grant 23
Aug 17, 2017: New Way To Empower The Immune System To Detect And Kill Cancer 24
May 03, 2017: New Pathway For Blood Cancer Therapies 25
Mar 01, 2017: Combination of ground-breaking treatments offer powerful new path for blood cancer therapies 26
Other Significant Developments 27
Feb 27, 2017: Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia University Medical Center and Peter MacCallum Cancer Centre 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Key Facts 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peter MacCallum Cancer Centre, Deals By Therapy Area, 2012 to YTD 2018 8
Peter MacCallum Cancer Centre, Medical Devices Deals, 2012 to YTD 2018 9
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 11
Telix Pharma Enters into Research Partnership with University of Melbourne and Peter MacCallum Cancer Centre 12
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 13
Peter MacCallum Cancer Centre, Key Employees 14
Peter MacCallum Cancer Centre, Joint Venture 15

List of Figures
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Peter MacCallum Cancer Centre, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Peter MacCallum Cancer Centre:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zoologischer Garten Berlin AG:企業の戦略・SWOT・財務情報
    Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report Summary Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Armune BioScience Inc:製品パイプライン分析
    Summary Armune BioScience Inc (Armune) is a medical device company that develops and commercializes molecular diagnostic and prognostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or proteins. It develops protein signature based diagnostic tests fo …
  • Titan Machinery Inc. (TITN):企業の財務・戦略的SWOT分析
    Titan Machinery Inc. (TITN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Synchrony Financial
    Synchrony Financial - Strategy, SWOT and Corporate Finance Report Summary Synchrony Financial - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Crown Resorts Ltd:企業の戦略・SWOT・財務情報
    Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ADM Tronics Unlimited Inc (ADMT):企業の財務・戦略的SWOT分析
    ADM Tronics Unlimited Inc (ADMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Pattern Energy Group Inc (PEGI):企業の財務・戦略的SWOT分析
    Pattern Energy Group Inc (PEGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Telenor ASA:企業の戦略・SWOT・財務情報
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Psychemedics Corp (PMD):企業の財務・戦略的SWOT分析
    Summary Psychemedics Corp (Psychemedics) is a clinical laboratory service provider. The company provides testing for drugs abuse using hair analysis. It offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzod …
  • Thirau Inc.:企業の戦略的SWOT分析
    Thirau Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • UMW Holdings Bhd (UMW)
    UMW Holdings Bhd (UMW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • OMV AG:企業の戦略・SWOT・財務情報
    OMV AG - Strategy, SWOT and Corporate Finance Report Summary OMV AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Miromatrix Medical Inc:企業の製品パイプライン分析
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a biotechnology company engaged in the development extracellular matrix based medical devices in soft tissue reinforcement and advanced wound care. The company offers MIRODERM a porcine liver-derived noncrosslinked acellular biologic wound matri …
  • Cargolux Airlines International S.A.:企業の戦略・SWOT・財務情報
    Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report Summary Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Solvay Specialty Polymers Italy SpA:企業の戦略的SWOT分析
    Solvay Specialty Polymers Italy SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Aveda Transportation and Energy Services Inc (AVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Aveda Transportation and Energy Services Inc (Aveda), formerly Phoenix Oilfield Hauling Inc is an oilfield service provider that offers energy transportation and other energy related services. The company provides specialized transportation services and equipment for drilling, exploration, d …
  • J&P – Avax Sa
    J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report Summary J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Empire Resorts Inc:戦略・SWOT・企業財務分析
    Empire Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Empire Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BASF Mexicana SA de CV:企業の戦略的SWOT分析
    BASF Mexicana SA de CV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Zh International Holdings Ltd
    Zh International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zh International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆